Nutranomics Inc (NNRX) 0.0002 $NNRX Nutranomics, Domaine

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nutranomics Inc (NNRX) 0.0002 $NNRX

Nutranomics, Domaine Global Prepare For Launch
ACCESSWIRE - Tue Jun 07, 9:04AM CDT
SALT LAKE CITY, UT / ACCESSWIRE / June 7, 2016 / NutraNomics, Inc. (OTC: NNRX) and Domaine Global are preparing to launch their combined marketing efforts for their Q3 roll out of products.

Small Healthcare Companies Sometimes Forgotten
PR Newswire - Fri May 27, 9:10AM CDT
The healthcare sector is large and diverse, with biotechs, drug manufacturers, health insurance companies all falling under its umbrella. A rather overlooked sector are the very small healthcare companies. While not often talked about, these healthcare companies are still trying to prove themselves. The United States is by far the largest consumer of the healthcare market in the world. Advanced Medical Isotope Corp. (OTC: ADMD), Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), Bioelectronics Corp (OTC: BIEL)

Completion of National Partnership With Domaine Global
ACCESSWIRE - Tue May 24, 7:01AM CDT
SALT LAKE CITY, UT / ACCESSWIRE / May 24, 2016 / NutraNomics (OTC: NNRX) has announced the completion of a national partnership with Domaine Global Healthcare based in Rockville, Maryland. This partnership includes a commitment to 10,000 healthcare clinics which will soon carry NutraNomics' Amazon Protocol line of products under its One Care brand.

Jonathan Bishop Appointed New CEO of Nutranomics
ACCESSWIRE - Thu Apr 21, 7:37AM CDT
SALT LAKE CITY, UT / ACCESSWIRE / April 21, 2016 / Nutranomics (OTC: NNRX) has announced the appointment of Jonathan Bishop as their new CEO. He will assume responsibilities on April 18, 2016 and will succeed Tracy Gibbs who has stepped down for personal reasons.

Nutranomics Receives Order from Southern California's Fastest Growing Health Food Store Chain
ACCESSWIRE - Wed Feb 10, 7:46AM CST
DRAPER, UT / ACCESSWIRE / February 10, 2016 / Nutranomics (OTC: NNRX) recently received a purchase order for 2000 bottles of its patented enzyme and full spectrum omega fish oil products from Nutrition Zone, one of the fastest-growing health food store chains in Southern California.

Nutranomics Introduces Newly Developed Formulas For OneCare(TM) Brand
ACCESSWIRE - Wed Jan 20, 8:00AM CST
DRAPER, UT / ACCESSWIRE / January 20, 2016 / Following the recent return of Dr. Tracy Gibbs to Nutranomics (PINKSHEETS: NNRX) as CEO, the company has solidified its sales and marketing strategy for 2016.

Nutranomics, Inc. Announces the Appointment of Company Founder, Dr. Tracy Gibbs, as CEO
Marketwired - Thu Jan 07, 8:30AM CST
Nutranomics, Inc (OTC PINK: NNRX) announces the re-instatement of company founder Dr. Tracy Gibbs as the company's CEO. Dr. Gibbs has previously served as CEO from Nutranomics' inception in 1995 until 2014. He has been the company's chief scientist and corporate visionary.

Penny Stocks Alerts for Urban Barns Foods, Buka Ventures, Hemp, GT Advanced Technologies, ANAVEX LIFE SCIENCES, and 3D EYE SOLUTIONS
PR Newswire - Mon Nov 02, 8:00AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Urban Barns Foods (OTCMKTS:URBF), Buka Ventures (OTCMKTS:NNRX), Hemp (OTCMKTS:HEMP), GT Advanced Technologies (OTCMKTS:GTATQ), ANAVEX LIFE SCIENCES (OTCMKTS:AVXLD), and 3D EYE SOLUTIONS (OTCMKTS:TDEY).
AVXL: 3.21 (unch)

Nutranomics, Inc. Issues Shareholder Letter
Marketwired - Wed Oct 14, 8:02AM CDT
Nutranomics, Inc. (OTC PINK: NNRX) ("Nutranomics" or "The Company", a diversified nutraceutical formulator, supplement manufacturer and marketer of Nutranomics(R) health supplements, today issued a Shareholder Letter (the "Letter". The Letter details challenges the Company endured during the last year, reports operational improvements to date, establishes strategies to regain sales momentum and provides options to finance the Company's growth.

Nutranomics appoints Dr Edward Eyring as CEO
M2 - Thu Oct 08, 5:41AM CDT
Nutranomics Inc (OTC PINK: NNRX), a diversified nutraceutical formulator, supplement manufacturer and marketer of Nutranomics health supplements, announced on Wednesday that it has appointed Dr Edward 'Joe' Eyring as CEO.

Dr. Edward Eyring Appointed to Chief Executive Officer of Nutranomics
Marketwired - Wed Oct 07, 7:00AM CDT
Nutranomics, Inc. (OTC PINK: NNRX) ("Nutranomics" or "The Company", a diversified nutraceutical formulator, supplement manufacturer and marketer of Nutranomics(R) health supplements, today announced the appointment of Dr. Edward "Joe" Eyring, past Board certified surgeon and healthcare entrepreneur, to assume CEO responsibilities from Mr. Michael Doron. Neither the Company nor Mr. Doron have cited any issues between parties, and Mr. Doron aided in the recruitment, review and transition of his role to Dr. Eyring.

NNRX USA's OEM & Formulation Sales Surge in February and March
ACCESSWIRE - Fri Apr 17, 9:00AM CDT
29% Year-over-Year Increase in 2015 February and March Sales Demonstrates a Trend Which the Company Anticipates to Continue Throughout the Year

NNRX USA, Inc. Issues Shareholder Letter and CEO Business Update
ACCESSWIRE - Mon Jan 05, 8:01AM CST
Michael Doron Provides Overview on New Directions for the Company and Strategies for 2015

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 53

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 292

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 49

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 26

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 135

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 32

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading
CICYBELL's Black Friday Is a Fashionist's Dream

Updated Category News Views 69

Stepping Into the Fashion Frenzy It’s that time of year again, where shoppers are girding up for Black Friday. And here comes CICYBELL, ready to dish up some meaty discounts that would turn even the most hardened cynic into a frenzied shopper. Alright, maybe that’s a touch dramatic, but let’s break down what this fashion brand is cooking up in their latest sale....

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 67

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 0

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Artprice News Revolutionizes Global Art Market Information

Updated Category News Views 237

Artprice News Launch: A New Chapter in Art Market Reporting Artprice by Artmarket has introduced a groundbreaking initiative with the launch of Artprice News, marking a significant evolution in the landscape of art market information. This innovative news agency is tailored exclusively for the art world, broadcasting valuable insights in 11 languages and spanning 122...

Continue Reading
U-BX Technology Ltd. Responds to Nasdaq Notification on Listing

Updated Category News Views 211

U-BX Technology Ltd. Responds to Nasdaq Notification U-BX Technology Ltd. (NASDAQ: UBXG), recognized as a frontrunner in offering innovative services powered by artificial intelligence to the insurance sector, recently informed stakeholders regarding important notifications received from The Nasdaq Stock Market LLC. Details of Nasdaq Notification Letters On a recent date,...

Continue Reading
Understanding Investor Rights in Newmont Securities Class Action

Updated Category News Views 370

Understanding the Basics of the Newmont Class Action Investors who have sustained losses exceeding $50,000 in Newmont Corporation should take heed of an active class action. This legal effort aims to provide relief for those affected by adverse developments within the company. Faruqi & Faruqi, LLP, a prominent securities law firm, is at the forefront of this investigation...

Continue Reading
Tarte's Record-Breaking Collab: 60 Seconds to Sellout

Updated Category News Views 129

When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...

Continue Reading
What Lessons Can Traditional Investors Learn From the Rise of Ethereum?

Updated Category Crypto Views 3176

Turn the clock back a few decades, and investors on Wall Street would laugh if you tried to pitch the concept of blockchain to them. It’s one of those ideas that sound like they’d technically work but would be impossible to practically execute. Yet today, blockchain and cryptocurrency exist and are proof that the skeptics were wrong. Sadly, many traditional investors...

Continue Reading